SciELO - Scientific Electronic Library Online

vol.31 issue1Incompatibility of intravenous drugs: Structured reviewSporotrichosis and chromoblastomycosis: literature review author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand



Related links

  • On index processCited by Google
  • Have no similar articlesSimilars in SciELO
  • On index processSimilars in Google


CES Medicina

Print version ISSN 0120-8705


ALVAREZ, María Fernanda; PALACIO-BARRIENTOS, Andrés; BOTERO-ARANGO, José Fernando  and  RAMIREZ-RINCON, Alex. Pumps in Type 2 diabetes, from basics to practice. CES Med. [online]. 2017, vol.31, n.1, pp.70-76. ISSN 0120-8705.

Insulin pumps have been used for over 35 years, mostly in patients with type 1 diabetes and to a lesser extent in type 2 diabetes. The use of pumps in this population is supported by a more physiological release of insulin, prevention of the dawn phenomenon and enabling patients to achieve better glucose targets. Pump indications in type 2 diabetes are less clear than in patients with type 1, but perhaps those who benefit most, are patients with a history of significant glycemic excursions, severe or asymptomatic hypoglycemia. Pump management as inpatient has been limited by lack of personal knowledge, however it has been reported that it is feasible to keep patients who are using this technology to continue it while they are in the hospital provided that a suitable protocol has been standardized and the patient has enough knowledge. Costs have been one of the most controversial issues with the use of these technology, cost-effectiveness analysis have found that there is a decrease in the number of oral agents, emergency room visits and insulin doses, reaching some studies to conclude that three years could offset the pump cost.

Keywords : Insulin infusion systems; Artificial pancreas, Type 2 diabetes, Hemoglobin A1c, Glycosylated; Hospital admission.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )